HomeCompareASNB vs JNJ

ASNB vs JNJ: Dividend Comparison 2026

ASNB yields 1058.82% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ASNB wins by $31071345.49M in total portfolio value
10 years
ASNB
ASNB
● Live price
1058.82%
Share price
$0.85
Annual div
$9.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31071345.51M
Annual income
$26,203,152,977,635.43
Full ASNB calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — ASNB vs JNJ

📍 ASNB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodASNBJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ASNB + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ASNB pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ASNB
Annual income on $10K today (after 15% tax)
$90,000.00/yr
After 10yr DRIP, annual income (after tax)
$22,272,680,030,990.11/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, ASNB beats the other by $22,272,680,030,286.50/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ASNB + JNJ for your $10,000?

ASNB: 50%JNJ: 50%
100% JNJ50/50100% ASNB
Portfolio after 10yr
$15535672.76M
Annual income
$13,101,576,489,231.60/yr
Blended yield
84.33%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ASNB
No analyst data
Altman Z
-0.8
Piotroski
1/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ASNB buys
0
JNJ buys
0
No recent congressional trades found for ASNB or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricASNBJNJ
Forward yield1058.82%3.36%
Annual dividend / share$9.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$31071345.51M$20.0K
Annual income after 10y$26,203,152,977,635.43$827.78
Total dividends collected$30702285.77M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ASNB vs JNJ ($10,000, DRIP)

YearASNB PortfolioASNB Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$116,582$105,882.35$10,676$355.77+$105.9KASNB
2$1,278,389$1,153,646.15$11,407$389.39+$1.27MASNB
3$13,190,644$11,822,767.40$12,198$426.53+$13.18MASNB
4$128,122,756$114,008,766.65$13,056$467.62+$128.11MASNB
5$1,172,030,327$1,034,938,978.31$13,987$513.12+$1172.02MASNB
6$10,102,040,479$8,847,968,029.27$14,998$563.56+$10102.03MASNB
7$82,083,001,031$71,273,817,718.63$16,098$619.52+$82082.98MASNB
8$629,069,410,336$541,240,599,232.35$17,295$681.69+$629069.39MASNB
9$4,549,712,643,140$3,876,608,374,080.81$18,599$750.82+$4549712.62MASNB
10$31,071,345,505,795$26,203,152,977,635.43$20,022$827.78+$31071345.49MASNB

ASNB vs JNJ: Complete Analysis 2026

ASNBStock

EKIMAS Corporation does not have significant operations. Previously, the company was engaged in the development of polymer materials for use in the design and development of medical devices used for treating a range of anatomical sites and disease states. It intends to identify, acquire, or merge with an operating company through an equity-based exchange transaction. The company was formerly known as AdvanSource Biomaterials Corporation and changed its name to EKIMAS Corporation in March 2020. EKIMAS Corporation was incorporated in 1993 and is based in Las Vegas, Nevada.

Full ASNB Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this ASNB vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ASNB vs SCHDASNB vs JEPIASNB vs OASNB vs KOASNB vs MAINASNB vs ABBVASNB vs MRKASNB vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.